The International Tennis Integrity Agency (ITIA) announced that Andrej Martin has been banned for 14 months after testing positive for the anabolic agent SARM S-22. At the Bratislava Challenger last June, former world No 93 Martin provided a sample that was tested for doping.
After the sample returned as positive for the anabolic agent SARM S-22, 33-year-old Martin was provisionally suspended by the ITIA. Martin's hearing in the case took place last month and he learned about his 14-month suspension earlier this month.
The ITIA announces Martin failed a doping test
"The International Tennis Integrity Agency (ITIA) has today confirmed that Slovak tennis player Andrej Martin has been banned for a period of 14 months following a breach of the Tennis Anti-Doping Programme (TADP), as determined by an independent Sport Resolutions panel.
33-year-old Martin, who reached a career-high ATP singles ranking of 93 in February 2020, was tested under the TADP at the Bratislava Open in June 2022. Subsequent analysis of the sample found presence of SARM S-22, an anabolic agent banned at all times under Section S1.2 (Other Anabolic Agents) of the 2022 WADA Prohibited List.
In accordance with the TADP, the period of ineligibility for a player’s first offence of this nature is up to four years, unless they can establish that the ADRV was not intentional, in which case the period of Ineligibility will be up to two years," the ITIA said in a statement.
In his explanation, Martin said he participated in a floorball tournament between June 03-06 and that he mistakenly ingested the anabolic agent SARM S-22 after mistaking his water bottle for one of his teammate. The Independent Tribunal accepted that Martin didn't purposely take the banned substance and took that into consideration when making the decision on the Slovak.
Last year, Martin competed in mostly Challenger tournaments and his best result of the year came at the Heilbronn Challenger, where she Slovak finished as runner-up.